000 01262 a2200361 4500
005 20250514005727.0
264 0 _c20010830
008 200108s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJMcp010145
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aToft, A D
245 0 0 _aClinical practice. Subclinical hyperthyroidism.
_h[electronic resource]
260 _bThe New England journal of medicine
_cAug 2001
300 _a512-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aAged
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAntithyroid Agents
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperthyroidism
_xcomplications
650 0 4 _aMethimazole
_xtherapeutic use
650 0 4 _aOsteoporosis
_xetiology
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aRisk Factors
650 0 4 _aThyroid Function Tests
650 0 4 _aThyrotropin
_xblood
650 0 4 _aThyroxine
_xadministration & dosage
773 0 _tThe New England journal of medicine
_gvol. 345
_gno. 7
_gp. 512-6
856 4 0 _uhttps://doi.org/10.1056/NEJMcp010145
_zAvailable from publisher's website
999 _c11443899
_d11443899